Mechanisms underlying neonatal hypoxia ischemia

Open Drug Discovery Journal

Volumn 2, Issue SPEC. ISS.3, 2010, Pages 129-137

  Kleman, Neil W ^a,b   Sun, Dandan ^a,b   Cengiz, Pelin ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; HOE 642 (cariporide); Na + H + exchanger isoform 1 (NHE 1); Neonatal hypoxia ischemia; NMDA

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ALLOPURINOL; DOCOSAHEXAENOIC ACID; ERYTHROPOIETIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MANGANESE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; NORPHENAZONE; PHENOBARBITAL; PROSTAGLANDIN SYNTHASE; SEVOFLURANE; SODIUM PROTON EXCHANGE PROTEIN; TOPIRAMATE; TUMOR NECROSIS FACTOR ALPHA; XENON;

APOPTOSIS; CONTRAST ENHANCEMENT; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; EXCITOTOXICITY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEWBORN HYPOXIA; NICK END LABELING; NISSL STAINING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STROMA CELL;

EID: 84863949080     PISSN: None     EISSN: 18773818     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Ferriero, D.M. Neonatal brain injury. N. Engl. J. Med., 2004, 351, 1985-1995.
2. Lafemina, M.J.; Sheldon, R.A.; Ferriero, D.M. Acute hypoxiaischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr. Res., 2006, 59, 680-683.
3. Johnston, M.V. Excitotoxicity in perinatal brain injury. Brain Pathol., 2005, 15, 234-240.
4. Aarts, M.M.; Tymianski, M. Novel treatment of excitotoxicity: targeted disruption of intracellular signaling from glutamate receptors. Biochem. Pharmacol., 2003, 66, 877-886.
5. Hansen, H.H.; Briem, T.; Dzietko, M.; Sifringer, M.; Voss, A.; Rzeski, W.; Zdzisinska, B.; Thor, F.; Heumann, R.; Stepulak, A.; Bittigau, P.; Ikonomidou, C. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol.Dis., 2004, 16, 440-453.
6. Ikonomidou, C.; Bosch, F.; Miksa, M.; Bittigau, P.; Vockler, J.; Dikranian, K.; Tenkova, T.I.; Stefovska, V.; Turski, L.; Olney, J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science, 1999, 283, 70-74.
7. Jiang, X.; Mu, D.; Biran, V.; Faustino, J.; Chang, S.; Rincon, C.M.; Sheldon, R.A.; Ferriero, D.M. Activated Src kinases interact with the N-methyl-D-aspartate receptor after neonatal brain ischemia. Ann. Neurol., 2008, 63, 632-641.
8. Rice, J.E. III, Vannucci, R.C.; Brierley, J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol., 1981, 9, 131-141.
9. Levine, S. Anoxic-ischemic encephalopathy in rats. Am. J. Pathol., 1960, 36, 1-17.
10. Vannucci, R.C.; Vannucci, S.J. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev. Neurosci., 2005, 27, 81-86.
11. Welsh, F.A.; Vannucci, R.C.; Brierley, J.B. Columnar alterations of NADH fluorescence during hypoxia-ischemia in immature rat brain. J. Cereb. Blood Flow Metab., 1982, 2, 221-228.
12. Barks, J.D.; Liu, Y.Q.; Shangguan, Y.; Li, J.; Pfau, J.; Silverstein, F.S. Impact of indolent inflammation on neonatal hypoxic-ischemic brain injury in mice. Int. J. Dev. Neurosci., 2008, 26, 57-65.
13. Doverhag, C.; Keller, M.; Karlsson, A.; Hedtjarn, M.; Nilsson, U.; Kapeller, E.; Sarkozy, G.; Klimaschewski, L.; Humpel, C.; Hagberg, H.; Simbruner, G.; Gressens, P.; Savman, K. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol. Dis., 2008, 31, 133-144.
14. Stone, B.S.; Zhang, J.; Mack, D.W.; Mori, S.; Martin, L.J.; Northington, F.J. Delayed neural network degeneration after neonatal hypoxia-ischemia. Ann. Neurol., 2008, 64, 535-546.
15. Liu, X.H.; Kwon, D.; Schielke, G.P.; Yang, G.Y.; Silverstein, F.S.; Barks, J.D. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J. Cereb. Blood Flow Metab., 1999, 19, 1099-1108.
16. Northington, F.J.; Ferriero, D.M.; Graham, E.M.; Traystman, R.J.; Martin, L.J. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol. Dis., 2001, 8, 207-219.
17. Nakanishi, N.; Tu, S.; Shin, Y.; Cui, J.; Kurokawa, T.; Zhang, D.; Chen, H.S.; Tong, G.; Lipton, S.A. Neuroprotection by the NR3A subunit of the NMDA receptor. J. Neurosci., 2009, 29, 5260-5265.
18. Kendall, G.S.; Robertson, N.J.; Iwata, O.; Peebles, D.; Raivich, G. N-methyl-isobutyl-amiloride ameliorates brain injury when commenced before hypoxia ischemia in neonatal mice. Pediatr. Res., 2006, 59, 227-231.
19. Tan, S.; Liu, Y.Y.; Nielsen, V.G.; Skinner, K.; Kirk, K.A.; Baldwin, S.T.; Parks, D.A. Maternal infusion of antioxidants (Trolox and ascorbic acid) protects the fetal heart in rabbit fetal hypoxia. Pediatr. Res., 1996, 39, 499-503.
20. Tan, S.; Zhou, F.; Nielsen, V.G.; Wang, Z.; Gladson, C.L.; Parks, D.A. Sustained hypoxia-ischemia results in reactive nitrogen and oxygen species production and injury in the premature fetal rabbit brain. J. Neuropathol. Exp. Neurol., 1998, 57, 544-553.
21. Sheldon, R.A.; Sedik, C.; Ferriero, D.M. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res., 1998, 810, 114-122.
22. Fiedorowicz, M.; Makarewicz, D.; Stanczak-Mrozek, K.I.; Grieb, P. CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia. Acta Neurobiol. Exp. (Wars.)., 2008, 68, 389-397.
23. Wang, X.; Carlsson, Y.; Basso, E.; Zhu, C.; Rousset, C.I.; Rasola, A.; Johansson, B.R.; Blomgren, K.; Mallard, C.; Bernardi, P.; Forte, M.A.; Hagberg, H. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J. Neurosci., 2009, 29, 2588-2596.
24. Cai, J.; Kang, Z.; Liu, K.; Liu, W.; Li, R.; Zhang, J.H.; Luo, X.; Sun, X. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res., 2009, 1256, 129-137.
25. Takizawa, Y.; Miyazawa, T.; Nonoyama, S.; Goto, Y.; Itoh, M. Edaravone inhibits DNA peroxidation and neuronal cell death in neonatal hypoxic-ischemic encephalopathy model rat. Pediatr. Res., 2009, 65, 636-641.
26. Iriyama, T.; Kamei, Y.; Kozuma, S.; Taketani, Y. Bax-inhibiting peptide protects glutamate-induced cerebellar granule cell death by blocking Bax translocation. Neurosci. Lett., 2009, 451, 11-15.
27. Northington, F.J.; Zelaya, M.E.; O'Riordan, D.P.; Blomgren, K.; Flock, D.L.; Hagberg, H.; Ferriero, D.M.; Martin, L.J. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as continuum phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience, 2007, 149, 822-833.
28. Schmued, L.C.; Stowers, C.C.; Scallet, A.C.; Xu, L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res., 2005, 1035, 24-31.
29. Wendland, M.F.; Faustino, J.; West, T.; Manabat, C.; Holtzman, D.M.; Vexler, Z.S. Early diffusion-weighted MRI as a predictor of caspase-3 activation after hypoxic-ischemic insult in neonatal rodents. Stroke, 2008, 39, 1862-1868.
30. Kuo, Y.T.; Herlihy, A.H.; So, P.W.; Bhakoo, K.K.; Bell, J.D. In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride. J. Magn Reson. Imaging, 2005, 21, 334-339.
31. Wideroe, M.; Olsen, O.; Pedersen, T.B.; Goa, P.E.; Kavelaars, A.; Heijnen, C.; Skranes, J.; Brubakk, A.M.; Brekken, C. Manganeseenhanced magnetic resonance imaging of hypoxic-ischemic brain injury in the neonatal rat. Neuroimage, 2009, 45, 880-890.
32. Palmada, M.; Centelles, J.J. Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain. Front Biosci., 1998, 20, d701-d718.
33. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. A family of metabotropic glutamate receptors. Neuron., 1992, 8, 169-179.
34. Xu, W.; Wong, T.P.; Chery, N.; Gaertner, T.; Wang, Y.T.; Baudry, M. Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron., 2007, 53, 399-412.
35. Rong, R.; Ahn, J.Y.; Huang, H.; Nagata, E.; Kalman, D.; Kapp, J.A.; Tu, J.; Worley, P.F.; Snyder, S.H.; Ye, K. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci., 2003, 6, 1153-1161.
36. Zhou, M.; Xu, W.; Liao, G.; Bi, X.; Baudry, M. Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Exp. Neurol., 2009, 218, 75-82.
37. Hossain, M.A. Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int. J. Dev. Neurosci., 2008, 26, 93-101.
38. Edinger, A.L.; Thompson, C.B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol., 2004, 16, 663-669.
39. Leist, M.; Jaattela, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol., 2001, 2, 589-598.
40. McDonald, J.W.; Behrens, M.I.; Chung, C.; Bhattacharyya, T.; Choi, D.W. Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res., 1997, 759, 228-232.
41. Broughton, B.R.; Reutens, D.C.; Sobey, C.G. Apoptotic mechanisms after cerebral ischemia. Stroke, 2009, 40, e331-e339.
42. Stefanis, L. Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist, 2005, 11, 50-62.
43. Aggarwal, S.; Gollapudi, S.; Gupta, S. Increased TNF-alphainduced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol., 1999, 162, 2154-2161.
44. Gill, M.B.; Perez-Polo, J.R. Hypoxia ischemia-mediated cell death in neonatal rat brain. Neurochem. Res., 2008, 33, 2379-2389.
45. Rao, R.V.; Castro-Obregon, S.; Frankowski, H.; Schuler, M.; Stoka, V.; del Rio, G.; Bredesen, D.E.; Ellerby, H.M. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem., 2002, 277, 21836-21842.
46. Beere, H.M.; Wolf, B.B.; Cain, K.; Mosser, D.D.; Mahboubi, A.; Kuwana, T.; Tailor, P.; Morimoto, R.I.; Cohen, G.M.; Green, D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol., 2000, 2, 469-475.
47. Saleh, A.; Srinivasula, S.M.; Balkir, L.; Robbins, P.D.; Alnemri, E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol., 2000, 2, 476-483.
48. Matsumori, Y.; Hong, S.M.; Aoyama, K.; Fan, Y.; Kayama, T.; Sheldon, R.A.; Vexler, Z.S.; Ferriero, D.M.; Weinstein, P.R.; Liu, J. Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab., 2005, 25, 899-910.
49. van den Tweel, E.R.; van Bel, F.; Kavelaars, A.; Peeters-Scholte, C.M.; Haumann, J.; Nijboer, C.H.; Heijnen, C.J.; Groenendaal, F. Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats. J. Cereb. Blood Flow Metab., 2005, 25, 67-74.
50. Kumral, A.; Yesilirmak, D.C.; Sonmez, U.; Baskin, H.; Tugyan, K.; Yilmaz, O.; Genc, S.; Gokmen, N.; Genc, K.; Duman, N.; Ozkan, H. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res., 2006, 1115, 169-178.
51. Ginet, V.; Puyal, J.; Magnin, G.; Clarke, P.G.; Truttmann, A.C. Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia. J. Neurochem., 2009, 108, 552-562.
52. Payton, K.S.; Sheldon, R.A.; Mack, D.W.; Zhu, C.; Blomgren, K.; Ferriero, D.M.; Northington, F.J. Antioxidant status alters levels of Fas-associated death domain-like IL-1B-converting enzyme inhibitory protein following neonatal hypoxia-ischemia. Dev. Neurosci., 2007, 29, 403-411.
53. Russell, J.C.; Szuflita, N.; Khatri, R.; Laterra, J.; Hossain, M.A. Transgenic expression of human FGF-1 protects against hypoxicischemic injury in perinatal brain by intervening at caspase-XIAP signaling cascades. Neurobiol. Dis., 2006, 22, 677-690.
54. Dugan, L.L.; Choi, D.W. Excitotoxicity, free radicals; cell membrane changes. Ann. Neurol., 1994, 35, S17-S21.
55. Walder, C.E.; Green, S.P.; Darbonne, W.C.; Mathias, J.; Rae, J.; Dinauer, M.C.; Curnutte, J.T.; Thomas, G.R. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke, 1997, 28, 2252-2258.
56. Hedtjarn, M.; Mallard, C.; Hagberg, H. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J. Cereb. Blood Flow Metab., 2004, 24, 1333-1351.
57. Dammann, O.; Kuban, K.C.; Leviton, A. Perinatal infection, fetal inflammatory response, white matter damage; cognitive limitations in children born preterm. Ment. Retard. Dev. Disabil. Res. Rev., 2002, 8, 46-50.
58. Perlman, J.M. Pathogenesis of hypoxic-ischemic brain injury. J. Perinatol., 2007, 27, S39-S46.
59. Hagberg, H.; Gilland, E.; Bona, E.; Hanson, L.A.; Hahin-Zoric, M.; Blennow, M.; Holst, M.; McRae, A.; Soder, O. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr. Res., 1996, 40, 603-609.
60. Bruce, A.J.; Boling, W.; Kindy, M.S.; Peschon, J.; Kraemer, P.J.; Carpenter, M.K.; Holtsberg, F.W.; Mattson, M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med., 1996, 2, 788-794.
61. Choi, D.W.; Rothman, S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. [Review] [96 refs]. Annu. Rev. Neurosci., 1990, 13, 171-182.
62. Cengiz, P.; Uluc, K.; Kleman, N.; Ferrazzano, P.; Sun, D. Effects of NA+/H+ exchanger isoform1 inhibitor cariporide on CA1 pyramidal neuronal death in mouse model of hyposic ischemic encephalopathy. XXIV International Symposium on Cerebral Blood Flow, Metabolism and Function of the International Society for Cerebral Blood Flow and Metabolism, 2009.
63. + exchanger isoform 1 is neuroprotective in neonatal hypoxic ischemic brain injury. Antioxid. Redox Signal., 2010, [Epub ahead of print].
64. + exchanger isoform 1 attenuates apoptosis and mitochondrial damage following transient focal cerebral ischemia. Eur. J. Neurosci., 2008, 28, 51-61.
65. Zhou, Y.; Fathali, N.; Lekic, T.; Tang, J.; Zhang, J.H. Glibenclamide improves neurological function in neonatal hypoxiaischemia in rats. Brain Res., 2009, 1270:131-9.
66. Luo, J.; Sun, D. Physiology and pathophysiology of Na(+)/H(+) exchange isoform 1 in the central nervous system. Curr. Neurovasc. Res., 2007, 4, 205-215.
67. + exchangers in rat central nervous system. Neuroscience, 1997, 79, 591-603.
68. + exchange inhibitors: potential mechanisms of action. Basic Res. Cardiol., 2001, 96, 306-311.
69. + exchanger is mediated through phosphorylation of amino acids Ser770 and Ser771. J. Biol. Chem., 2007, 282, 6292-6299.
70. Kintner, D.B.; Wang, Y.; Sun, D. Role of membrane ion transport proteins in cerebral ischemic damage. Front Biosci., 2007, 12, 762-770.
71. 2+ exchange inhibitors in attenuating ischemia-reperfusion injury. Can. J. Cardiol., 2005, 21, 509-516.
72. + exchanger 1 (NHE1) and neuroprotective effects of NHE inhibitor in the gerbil hippocampal CA1 region induced by transient ischemia. Exp. Neurol., 2008, 212, 314-323.
73. 2+ and ATP in native reactive astrocytes from adult rat brain. J. Neurosci., 2001, 21, 6512-6521.
74. Simard, J.M.; Chen, M.; Tarasov, K.V.; Bhatta, S.; Ivanova, S.; Melnitchenko, L.; Tsymbalyuk, N.; West, G.A.; Gerzanich, V. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med., 2006, 12, 433-440.
75. Liu, C.; Lin, N.; Wu, B.; Qiu, Y. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res., 2009, 1282, 173-182.
76. Chen, H.S.; Wang, Y.F.; Rayudu, P.V.; Edgecomb, P.; Neill, J.C.; Segal, M.M.; Lipton, S.A.; Jensen, F.E. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience, 1998, 86, 1121-1132.
77. Manning, S.M.; Talos, D.M.; Zhou, C.; Selip, D.B.; Park, H.K.; Park, C.J.; Volpe, J.J.; Jensen, F.E. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J. Neurosci., 2008, 28, 6670-6678.
78. Luo, Y.; Ma, D.; Ieong, E.; Sanders, R.D.; Yu, B.; Hossain, M.; Maze, M. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology, 2008, 109, 782-789.
79. Ohsawa, I.; Ishikawa, M.; Takahashi, K.; Watanabe, M.; Nishimaki, K.; Yamagata, K.; Katsura, K.; Katayama, Y.; Asoh, S.; Ohta, S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med., 2007, 13, 688-694.
80. Petridou, E.; Koussouri, M.; Toupadaki, N.; Youroukos, S.; Papavassiliou, A.; Pantelakis, S.; Olsen, J.; Trichopoulos, D. Diet during pregnancy and the risk of cerebral palsy. Br. J. Nutr., 1998, 79, 407-412.
81. Berman, D.R.; Mozurkewich, E.; Liu, Y.; Barks, J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am. J. Obstet. Gynecol., 2009, 200, 305-306.
82. Wei, X.; Du, Z.; Zhao, L.; Feng, D.; Wei, G.; He, Y.; Tan, J.; Lee, W.H.; Hampel, H.; Dodel, R.; Johnstone, B.H.; March, K.L.; Farlow, M.R.; Du, Y. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells, 2009, 27, 478-488.
83. Lin, S.; Fan, L.W.; Rhodes, P.G.; Cai, Z. Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp. Neurol., 2009, 217, 361-370.
84. Park, K.I.; Himes, B.T.; Stieg, P.E.; Tessler, A.; Fischer, I.; Snyder, E.Y. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp. Neurol., 2006, 199, 179-190.
85. Park, K.I.; Hack, M.A.; Ourednik, J.; Yandava, B.; Flax, J.D.; Stieg, P.E.; Gullans, S.; Jensen, F.E.; Sidman, R.L.; Ourednik, V.; Snyder, E.Y. Acute injury directs the migration, proliferation; differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal reporter neural stem cells. Exp. Neurol., 2006, 199, 156-178.
86. de Paula, S.; Vitola, A.S.; Greggio, S.; de Paula, D.; Mello, P.B.; Lubianca, J.M.; Xavier, L.L.; Fiori, H.H.; Dacosta, J.C. Hemispheric brain injury and behavioral deficits induced by severe neonatal hypoxia-ischemia in rats are not attenuated by intravenous administration of human umbilical cord blood cells. Pediatr. Res., 2009, 65, 631-635.
87. Xiong, M.; Yang, Y.; Chen, G.Q.; Zhou, W.H. Post-ischemic hypothermia for 24h in P7 rats rescues hippocampal neuron: association with decreased astrocyte activation and inflammatory cytokine expression. Brain Res. Bull., 2009, 79, 351-357.
88. Goldberg, R.N.; Moscoso, P.; Bauer, C.R.; Bloom, F.L.; Curless, R.G.; Burke, B.; Bancalari, E. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J. Pediatr., 1986, 109, 851-856.
89. Singh, D.; Kumar, P.; Narang, A. A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy. J. Matern. Fetal Neonatal Med., 2005, 18, 391-395.
90. Hall, R.T.; Hall, F.K.; Daily, D.K. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J. Pediatr., 1998, 132, 345-348.
91. Shalak, L.; Perlman, J.M. Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum. Dev., 2004, 80, 125-141.
92. Pacher, P.; Nivorozhkin, A.; Szabo, C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., 2006, 58, 87-114.
93. Benders, M.J.; Bos, A.F.; Rademaker, C.M.; Rijken, M.; Torrance, H.L.; Groenendaal, F.; van Bel, F. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch. Dis. Child Fetal Neonatal. Ed., 2006, 91, F163-F165.
94. Clancy, R.R.; McGaurn, S.A.; Goin, J.E.; Hirtz, D.G.; Norwood, W.I.; Gaynor, J.W.; Jacobs, M.L.; Wernovsky, G.; Mahle, W.T.; Murphy, J.D.; Nicolson, S.C.; Steven, J.M.; Spray, T.L. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics., 2001, 108, 61-70.
95. Chong, Z.Z.; Kang, J.Q.; Maiese, K. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J. Hematother. Stem Cell Res., 2002, 11, 863-871.
96. Juul, S.E.; Yachnis, A.T.; Rojiani, A.M.; Christensen, R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol., 1999, 2, 148-158.
97. Villa, P.; Bigini, P.; Mennini, T.; Agnello, D.; Laragione, T.; Cagnotto, A.; Viviani, B.; Marinovich, M.; Cerami, A.; Coleman, T.R.; Brines, M.; Ghezzi, P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med., 2003, 198, 971-975.
98. Gonzalez, F.F.; Abel, R.; Almli, C.R.; Mu, D.; Wendland, M.; Ferriero, D.M. Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev. Neurosci., 2009, 31, 403-411.
99. Zhu, C.; Kang, W.; Xu, F.; Cheng, X.; Zhang, Z.; Jia, L.; Ji, L.; Guo, X.; Xiong, H.; Simbruner, G.; Blomgren, K.; Wang, X. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics., 2009, 124, e218-e226.
100. Gluckman, P.D.; Wyatt, J.S.; Azzopardi, D.; Ballard, R.; Edwards, A.D.; Ferriero, D.M.; Polin, R.A.; Robertson, C.M.; Thoresen, M.; Whitelaw, A.; Gunn, A.J. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet, 2005, 365, 663-670.
101. Shankaran, S.; Laptook, A.R.; Ehrenkranz, R.A.; Tyson, J.E.; McDonald, S.A.; Donovan, E.F.; Fanaroff, A.A.; Poole, W.K.; Wright, L.L.; Higgins, R.D.; Finer, N.N.; Carlo, W.A.; Duara, S.; Oh, W.; Cotten, C.M.; Stevenson, D.K.; Stoll, B.J.; Lemons, J.A.; Guillet, R.; Jobe, A.H. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med., 2005, 353, 1574-1584.
102. Laptook, A.R. Use of therapeutic hypothermia for term infants with hypoxic-ischemic encephalopathy. Pediatr. Clin. North Am., 2009, 56, 601-616.